Clinical trial Recruiting at 1 site Observational Ages 18 and up

Understanding heart injury in patients with rapid atrial fibrillation

Official title: Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation

Run by University of Edinburgh · NCT06951100 · Data updated 2026-11-12

This study is trying to see if people with rapid atrial fibrillation and heart injury are more likely to have blocked arteries compared to those without heart injury, using blood tests and heart imaging.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorUniversity of Edinburgh
Academic / other
Locations1 site (Edinburgh, East of England)
StatusRecruiting
StartedMay 1, 2025
Main results expectedDecember 2026
Study endsOctober 2029
Registry record updatedOctober 26, 2026
Trial IDNCT06951100 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and over presenting with symptoms of rapid atrial fibrillation and a ventricular rate greater than 100 bpm.

Probably not a fit

Patients with a history of myocardial infarction, coronary revascularization, or significant renal failure may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the relationship between rapid atrial fibrillation (AF) and myocardial injury, focusing on the role of troponin levels and coronary imaging. It seeks to determine if patients with rapid AF and heart damage are more likely to have obstructive coronary artery disease compared to those without heart damage. Additionally, the study will assess whether these patients show signs of myocardial ischemia and infarction through various heart imaging techniques. Participants will undergo blood tests and advanced imaging, including electrocardiograms, echocardiograms, CT scans, and cardiac MRIs.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic strategies for patients with rapid atrial fibrillation and associated heart injuries.

How similar studies have gone: Other studies have explored similar relationships between atrial fibrillation and myocardial injury, suggesting potential for meaningful insights, though this specific approach may be novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18 years and over
2. Primary presentation with symptoms related to atrial fibrillation
3. Atrial fibrillation with a ventricular rate \>100 bpm on a 12-lead electrocardiogram
4. Able to provide informed consent

Exclusion Criteria

1. Previous myocardial infarction
2. Previous coronary revascularisation procedure
3. Patients in renal failure (eGFR \<30ml/min/1.73m2) or major allergy to contrast media
4. Pregnancy or breast feeding
5. Deemed unsuitable for participation in the study by the attending clinician
6. Previous enrolment in the trial

Where it's running

  • Royal Infirmary of Edinburgh
    Edinburgh, East of England, United Kingdom
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.